期刊文献+

外输泵抑制剂对喹诺酮抗凝固酶阴性葡萄球菌活性的影响

Efflux pump inhibitor on the activities of quinolones against coagulase-negative staphylococci
暂未订购
导出
摘要 测定了单独使用 3种喹诺酮类抗生素及与外输泵抑制剂利血平 (2 0 μg/ml)结合使用 ,对临床分离的 2 2株凝固酶阴性葡萄球菌的MIC。结果表明 ,利血平使个别敏感菌株和中低度耐药菌株的MIC降低 ,说明其存在外输泵介导的耐药表型 ;而对喹诺酮高度耐药菌株的MIC却没有受到影响 ,一些菌株的MIC甚至变大。另外 ,利血平对亲水性喹诺酮影响较大 。 The activities of 3 quinolones or quinolone plus efflux pump inhibitor(reserpine) were tested against 22 clinical isolates of coagulase negative staphylococci Reserpine(20 μg/ml) decreased MIC of hydropilic quinolone against susceptible coagulase negative staphylococci and median or lowly resistant coagulase negative staphylococci This indicates a major contribution of efflux pumps to the resistance phenotype in some strains No effect of reserpine on the activities of the quinolones against highly resistant S. aureus were observed Unexpectedly, the combination of reserpine and quinolone produced an increase of MIC in one strain Reserpine produced a bigger decrease in the MIC of hydrophilic quinolones compared to hydrophobic ones
出处 《广州医药》 2002年第3期49-51,共3页 Guangzhou Medical Journal
关键词 外输泵抑制剂 凝固酶阴性葡萄球菌 最低抑菌浓度 喹诺酮 实验研究 Efflux pump inhibitor Coagulase negative staphylococci Minimuninhinitory concentration(MIC)
  • 相关文献

参考文献2

二级参考文献20

  • 1杨素贞,赵乃江,田湘青,季桂芳,孙荫.临床292株葡萄球菌的实验研究[J].上海医学检验杂志,1994,9(2):85-86. 被引量:4
  • 2[1]Ubukata K, Itoh NY, Konno M, et al. Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus. [J]. Antimicrob Agents Chemother, 1989, 33(9): 1535
  • 3[2]Yoshida H, Bogaki M, Nakamura S, et al. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. [J]. J Bacteriol,1990, 172(12): 6942
  • 4[3]Kaatz GW, Seo SM, Ruble CA, et al. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. [J].Antimicrob Agents Chemother, 1993, 37(5): 1086
  • 5[4]Sierra JM, Ruiz J, Jimenez DMT, et al. Prevalence of two different genes encoding NorA in 23 clinical strains of Staphylococcus aureus. [J]. J Antimicrob Chemother,2000, 46(1): 145
  • 6[5]Ng EYW, Trucksis M, Hooper DC. Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome. [J]. Antimicrob Agents Chemother, 1994, 38(6): 1345
  • 7[6]Fournier B, Aras R, Hooper DC. Expression of the multidrug resistance transporter NorA from Staphylococcus aureus is modified by a two-component regulatory system.[J]. J Bacteriol, 2000, 182(3): 664
  • 8[7]Kaatz GW, Seo SM. Inducible NorA-mediated multidrug resistance in Staphylococcus aureus. [J]. Antimicrob Agents Chemother, 1995, 39(12): 2650
  • 9[8]Munoz-Bellido JL, Alonso MM, Martinez JA, et al. Efflux pump-mediated quinolone resistance in Staphylococcus aureus strains wild type for gyrA, gyrB, grlA and norA.[J]. Antimicrob Agents Chemother, 1999, 43(2): 354
  • 10[9]Kaatz GW, Seo SM, Foster TJ. Intriduction of a norA promoter region mutation into the chromosome of a fluoroquinolone-susceptible strain of Staphylococcus aureus using plasmid intergration. [J ]. Antimicrob Agents Chemother, 1999, 43(9): 2222

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部